INS and obesity due to melanocortin 4 receptor deficiency: However, given reports of metabolically-benign obesity [9] and the belief that insulin resistance drives the increased risk of cardiovascular events in obese individuals [16], we assessed the utility of LFP >4% in identifying insulin-resistant patients.